Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Benmammar KE"'
Autor:
Balayssac D; INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France. dbalayssac@chu-clermontferrand.fr., Kerckhove N; INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France., Selvy M; INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France., Pereira B; Direction à la Recherche Clinique et de l'Innovation, CHU Clermont-Ferrand, F-63000, Clermont-Ferrand, France., Gonneau C; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France., Pétorin C; Service Oncologie digestive, CHU Clermont-Ferrand, F-63000, Clermont-Ferrand, France., Vimal-Baguet A; Service Oncologie digestive, CHU Clermont-Ferrand, F-63000, Clermont-Ferrand, France., Melnikov S; Service Chirurgie générale et viscérale, Centre Hospitalier de Saint-Flour, F-15100, Saint-Flour, France., Kullab S; Service Oncologie, Centre Hospitalier de Moulins Yzeure, F-03006, Moulins, France., Hebbar M; Service Oncologie, CHRU Lille, F-59000, Lille, France., Bouché O; CHU Reims, Service Oncologie digestive, BioSpecT, Université de Reims Champagne-Ardenne, F-51100, Reims, France., Slimano F; CHU Reims, Service Pharmacie, BioSpecT, Université de Reims Champagne-Ardenne, EA n 7506, SFR CAP-Santé, F-51100, Reims, France., Bourgeois V; Service Oncologie digestive, Centre Hospitalier de Boulogne sur Mer, F-62321, Boulogne-Sur-Merv, France., Lebrun-Ly V; Service Oncologie, CHU Limoges, F-87042, Limoges, France., Thuillier F; Service Oncologie, CHU Limoges, F-87042, Limoges, France., Mazard T; IRCM, Inserm, ICM, Univ Montpellier, F-34298, Montpellier, France., Tavan D; Service Gastro-entérologie, Infirmerie Protestante de Lyon, F-69300, Caluire et Cuire, France., Benmammar KE; Service Oncologie, Centre Hospitalier Emile Roux, F-43000, Le Puy-en-Velay, France., Monange B; Service Oncologie, Centre Hospitalier Emile Roux, F-43000, Le Puy-en-Velay, France., Ramdani M; Service Gastro-entérologie, Centre Hospitalier de Béziers, F-34500, Béziers, France., Péré-Vergé D; Service Hépato-gastro-entérologie, Centre Hospitalier Saint-Joseph Saint-Luc, F-69007, Lyon, France., Huet-Penz F; Service Gastro entérologie, Centre Hospitalier Alpes Leman, F-74130, Contamine sur Arve, France., Bedjaoui A; Service Gastro-entérologie, Centre hospitalier Intercommunal Les Hôpitaux du Léman, F-74203, Thonon les bains, France., Genty F; Service Chirurgie digestive et viscérale, Centre Hospitalier de Vichy, F-03200, Vichy, France., Leyronnas C; Groupe Hospitalier Mutualiste de Grenoble, Service Oncologie, F-38000, Grenoble, France., Pezet D; UFRs de Médecine et de Pharmacie, INSERM U1071, M2iSH, USC-INRA 2018, CHU Clermont-Ferrand, Université Clermont Auvergne, F-63000, Clermont-Ferrand, France., Martin V; AME2P, Clermont-Ferrand, Institut Universitaire de France (IUF), Université Clermont Auvergne, F-63000, Paris, France.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jun 13; Vol. 32 (7), pp. 427. Date of Electronic Publication: 2024 Jun 13.
Autor:
Kerckhove N; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, Clermont-Ferrand, France.; Délégation à La Recherche Clinique et à L'Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France.; Institut Analgesia, Université Clermont Auvergne, Clermont-Ferrand, France., Selvy M; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, Clermont-Ferrand, France., Lambert C; Délégation à La Recherche Clinique et à L'Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France., Gonneau C; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, Clermont-Ferrand, France., Feydel G; Délégation à La Recherche Clinique et à L'Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France., Pétorin C; Service Oncologie Digestive, CHU Clermont-Ferrand, Clermont-Ferrand, France., Vimal-Baguet A; Service Oncologie Digestive, CHU Clermont-Ferrand, Clermont-Ferrand, France., Melnikov S; Service Chirurgie Générale et Viscérale, Centre Hospitalier de Saint-Flour, Saint-Flour, France., Kullab S; Service Oncologie, Centre Hospitalier de Moulins Yzeure, Moulins, France., Hebbar M; CHRU Lille, Service Oncologie, Lille, France., Bouché O; Service Oncologie Digestive, CHU Reims, Université de Reims Champagne-Ardenne, Reims, France., Slimano F; Service Pharmacie, CHU Reims, BioSpect, SFR CAP-Santé, Université de Reims Champagne-Ardenne, Reims, France., Bourgeois V; Service Oncologie Digestive, Centre Hospitalier de Boulogne sur Mer, Boulogne-Sur-Mer, France., Lebrun-Ly V; Service Oncologie, CHU Limoges, Limoges, France., Thuillier F; Service Oncologie, CHU Limoges, Limoges, France., Mazard T; IRCM, Inserm, Univ Montpellier, ICM, Montpellier, France., Tavan D; Service Gastro-entérologie, Infirmerie Protestante de Lyon, Caluire et Cuire, France., Benmammar KE; Service Oncologie, Centre Hospitalier Emile Roux, Le Puy-en-Velay, France., Monange B; Service Oncologie, Centre Hospitalier Emile Roux, Le Puy-en-Velay, France., Ramdani M; Service Gastro-entérologie, Centre Hospitalier de Béziers, Béziers, France., Péré-Vergé D; Service Hépato-gastro-entérologie, Centre Hospitalier Saint-Joseph Saint-Luc, Lyon, France., Huet-Penz F; Service Gastro Entérologie, Centre Hospitalier Alpes Leman, Contamine sur Arve, France., Bedjaoui A; Service Gastro-entérologie, Centre Hospitalier Intercommunal Les Hôpitaux Du Léman, Thonon Les Bains, France., Genty F; Service Chirurgie Digestive et Viscérale, Centre Hospitalier de Vichy, Vichy, France., Leyronnas C; Service Oncologie, Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France., Busserolles J; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, Clermont-Ferrand, France.; Institut Analgesia, Université Clermont Auvergne, Clermont-Ferrand, France., Trévis S; Service Pharmacie, CHU Clermont-Ferrand, Clermont-Ferrand, Clermont-Ferrand, France., Pinon V; Service Pharmacie, CHU Clermont-Ferrand, Clermont-Ferrand, Clermont-Ferrand, France., Pezet D; INSERM, M2iSH, USC-INRA 2018, Université Clermont Auvergne, CHU Clermont-Ferrand, Clermont-Ferrand, France., Balayssac D; INSERM U1107 NEURO-DOL, Université Clermont Auvergne, Clermont-Ferrand, France.; Délégation à La Recherche Clinique et à L'Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2021 Nov 04; Vol. 12, pp. 744085. Date of Electronic Publication: 2021 Nov 04 (Print Publication: 2021).
Autor:
Selvy M; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Pereira B; CHU Clermont-Ferrand, Délégation à la Recherche Clinique et à l'Innovation, F-63000 Clermont-Ferrand, France., Kerckhove N; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Gonneau C; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, F-63000 Clermont-Ferrand, France., Feydel G; CHU Clermont-Ferrand, Délégation à la Recherche Clinique et à l'Innovation, F-63000 Clermont-Ferrand, France., Pétorin C; CHU Clermont-Ferrand, Service Oncologie digestive, F-63000 Clermont-Ferrand, France., Vimal-Baguet A; CHU Clermont-Ferrand, Service Oncologie digestive, F-63000 Clermont-Ferrand, France., Melnikov S; Centre Hospitalier de Saint-Flour, Service Chirurgie générale et viscérale, F-15100 Saint-Flour, France., Kullab S; Centre Hospitalier de Moulins Yzeure, Service Oncologie, F-03006 Moulins, France., Hebbar M; CHRU Lille, Service Oncologie, F-59000 Lille, France., Bouché O; CHU Reims, Service Oncologie digestive, Université de Reims Champagne-Ardenne, F-51100 Reims, France., Slimano F; CHU Reims, Service Pharmacie, BioSpecT, EA n 7506, SFR CAP-Santé, Université de Reims Champagne-Ardenne, F-51100 Reims, France., Bourgeois V; Centre Hospitalier de Boulogne sur Mer, Service Oncologie digestive, F-62321 Boulogne-Sur-Mer, France., Lebrun-Ly V; CHU Limoges, Service Oncologie, F-87042 Limoges, France., Thuillier F; CHU Limoges, Service Oncologie, F-87042 Limoges, France., Mazard T; IRCM, Inserm, Univ Montpellier, ICM, F-34298 Montpellier, France., Tavan D; Infirmerie protestante de Lyon, Service Gastro-entérologie, F-69300 Caluire et Cuire, France., Benmammar KE; Centre Hospitalier Emile Roux, Service Oncologie, F-43000 Le Puy-en-Velay, France., Monange B; Centre Hospitalier Emile Roux, Service Oncologie, F-43000 Le Puy-en-Velay, France., Ramdani M; Centre Hospitalier de Béziers, Service Gastro-entérologie, F-34500 Béziers, France., Péré-Vergé D; Centre hospitalier Saint-Joseph Saint-Luc, Service Hépato-gastro-entérologie, F-69007 Lyon, France., Huet-Penz F; Centre Hospitalier Alpes Leman, Service Gastro entérologie, F-74130 Contamine sur Arve, France., Bedjaoui A; Centre hospitalier Intercommunal Les Hôpitaux du Léman, Service Gastro-entérologie, F-74203 Thonon les bains, France., Genty F; Centre Hospitalier de Vichy, Service Chirurgie digestive et viscérale, F-03200 Vichy, France., Leyronnas C; Groupe Hospitalier Mutualiste de Grenoble, Service Oncologie, F-38000 Grenoble, France., Busserolles J; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, F-63000 Clermont-Ferrand, France., Trevis S; CHU Clermont-Ferrand, Service Pharmacie, Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Pinon V; CHU Clermont-Ferrand, Service Pharmacie, Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Pezet D; Université Clermont Auvergne, INSERM U1071, M2iSH, USC-INRA 2018, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France., Balayssac D; Université Clermont Auvergne, INSERM U1107 NEURO-DOL, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2020 Jul 27; Vol. 9 (8). Date of Electronic Publication: 2020 Jul 27.
Autor:
Nabholtz JM; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; CIC 501, UMR 766, Clermont-Ferrand, France.; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Chalabi N; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; CIC 501, UMR 766, Clermont-Ferrand, France., Radosevic-Robin N; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Dauplat MM; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Mouret-Reynier MA; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Van Praagh I; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Servent V; Oscar Lambret Comprehensive Cancer Centre, Lille, France., Jacquin JP; Lucien Neuwirth Institute, Saint-Etienne, France., Benmammar KE; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Kullab S; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Bahadoor MR; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; Oncauvergne Regional Oncology Network, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Kwiatkowski F; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Cayre A; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Abrial C; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; CIC 501, UMR 766, Clermont-Ferrand, France., Durando X; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; CIC 501, UMR 766, Clermont-Ferrand, France.; Medical Oncology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; EA 3846, University of Auvergne, Clermont-Ferrand, France., Bignon YJ; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France., Chollet P; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.; Inserm UMR 990, Clermont-Ferrand, France.; University of Auvergne Clermont-Ferrand, Clermont-Ferrand, France., Penault-Llorca F; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand, France.; Department of Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France.
Publikováno v:
International journal of cancer [Int J Cancer] 2016 May 01; Vol. 138 (9), pp. 2274-80. Date of Electronic Publication: 2015 Dec 28.
Autor:
Wang-Lopez Q; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; Inserm UMR 990, 63000 Clermont-Ferrand, France., Chalabi N; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France., Abrial C; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France., Radosevic-Robin N; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France., Durando X; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; CIC 501, UMR 766, 63003 Clermont-Ferrand, France; CREAT EA 7283, University of Auvergne, 63000 Clermont-Ferrand, France., Mouret-Reynier MA; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France., Benmammar KE; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France., Kullab S; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France., Bahadoor M; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France., Chollet P; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; Inserm UMR 990, 63000 Clermont-Ferrand, France., Penault-Llorca F; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France. Electronic address: Frederique.PENAULT-LLORCA@cjp.fr., Nabholtz JM; Jean Perrin Comprehensive Cancer Centre, 63011 Clermont-Ferrand, France; ERTICA EA 4677, University of Auvergne, 63000 Clermont-Ferrand, France.
Publikováno v:
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2015 Jul; Vol. 95 (1), pp. 88-104. Date of Electronic Publication: 2015 Mar 04.
Autor:
Nabholtz JM; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand jmnabholtz@cjp.fr., Abrial C; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand., Mouret-Reynier MA; ERTICA EA 4677, University of Auvergne, Clermont-FerrandDepartments of Medical Oncology, Clermont-Ferrand., Dauplat MM; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand., Weber B; Alexis Vautrin Comprehensive Cancer Centre, Nancy., Gligorov J; Tenon University Hospital, Paris., Forest AM; Montluçon Hospital Centre, Montluçon., Tredan O; Leon Berard Comprehensive Cancer Centre, Lyon., Vanlemmens L; Oscar Lambret Comprehensive Cancer Centre, Lille., Petit T; Paul Strauss Comprehensive Cancer Centre, Strasbourg., Guiu S; Georges François Leclerc Comprehensive Cancer Centre, Dijon., Van Praagh I; Departments of Medical Oncology, Clermont-Ferrand., Jouannaud C; Jean Godinot Comprehensive Cancer Institute, Reims., Dubray-Longeras P; ERTICA EA 4677, University of Auvergne, Clermont-FerrandDepartments of Medical Oncology, Clermont-Ferrand., Tubiana-Mathieu N; Limoges University Hospital, Limoges., Benmammar KE; Departments of Medical Oncology, Clermont-Ferrand., Kullab S; Departments of Medical Oncology, Clermont-Ferrand., Bahadoor MR; Departments of Medical Oncology, Clermont-Ferrand Oncauvergne Regional Oncology Network., Radosevic-Robin N; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand., Kwiatkowski F; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand., Desrichard A; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand., Cayre A; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand., Uhrhammer N; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand LMB GenAuvergne Oncogenetics Department, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand., Chalabi N; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand CIC 501, UMR 766, Clermont-Ferrand., Chollet P; Clinical and Translational Research Division, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand Inserm UMR 990, Clermont-Ferrand University of Auvergne, Clermont-Ferrand, France., Penault-Llorca F; ERTICA EA 4677, University of Auvergne, Clermont-Ferrand Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2014 Aug; Vol. 25 (8), pp. 1570-7. Date of Electronic Publication: 2014 May 14.